ArticlePharmaceutics2020

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats.

Shao-Jung Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.